Safety/Quality

Latest Issue of OR Manager
March 2025
Home Safety/Quality

More anesthesiology residency positions may help with staffing costs, workforce shortages

Editor's Note Adding more anesthesiology residency positions, even without federal funding, may help hospitals save staffing costs and address shortages of anesthesia personnel, finds a study presented January 27 at the American Society of Anesthesiologists’ ADVANCE 2023, in Orlando, Florida. Researchers from the University of Pittsburgh Medical Center compared the…

Read More

By: Judy Mathias
February 1, 2023
Share

37% of aspiring nurses in fraudulent degree scheme passed NCLEX

Editor's Note The New York Times on January 27 reported that 37% of aspiring nurses who allegedly purchased fraudulent degrees to bypass coursework and training required to sit for the National Council Licensure Examination (NCLEX) passed the test. Many of the 7,600 individuals who paid between $10,000 and $15,000 for…

Read More

By: Judy Mathias
February 1, 2023
Share

FDA: Class I recall of Medtronic Mahurkar Acute Dual Lumen High Flow Hemodialysis Catheters

Editor's Note The Food and Drug Administration (FDA) on January 30 identified the recall by Medtronic of its Mahurkar Acute Dual Lumen High Flow (13.5 French) Hemodialysis Catheters (Mahurkar QPlus) as Class I, the most serious. The recall was initiated because of a potential catheter hub defect that may cause…

Read More

By: Judy Mathias
February 1, 2023
Share

COVID-19 national, public health emergencies to end May 11

Editor's Note The Biden administration announced on January 30 that it will end the COVID-19 national and public health emergencies on May 11, the January 31 APnews reports. The move gives healthcare providers and other stakeholders about 100 days to prepare for the termination. The national and public health emergencies…

Read More

By: Judy Mathias
January 31, 2023
Share

Sponsored Message

FDA proposes individual risk assessment for donating blood

Editor's Note The Food and Drug Administration (FDA) on January 27 announced that it is proposing to ease blood donation restrictions by focusing on behavior rather than gender and sexual identity. Under current rules, the FDA allows donations from gay and bisexual men if they haven’t had sex with another…

Read More

By: Judy Mathias
January 31, 2023
Share

Hospital quality, neighborhood deprivation linked to postop mortality

Editor's Note This study led by researchers from the University of Michigan, Ann Arbor, finds that characteristics of patients’ neighborhoods and hospitals where they received treatment were both associated with postoperative mortality. This analysis included 1,898,829 Medicare beneficiaries from all neighborhood types undergoing one of five common surgical procedures in…

Read More

By: Judy Mathias
January 30, 2023
Share

Sponsored Message

State Boards of Nursing investigating fraudulent degrees

Editor's Note State Boards of Nursing are investigating those who allegedly bought fraudulent nursing degrees and diplomas as part of a widespread scheme to fast-track the process to take the National Council Licensure Examination, the January 27 Becker’s Hospital Review reports. Twenty-five individuals have been charged by the Justice Department…

Read More

By: Judy Mathias
January 30, 2023
Share

FDA: Addition to Class I recall of LivaNova LifeSPARC System Controller

Editor's Note The Food and Drug Administration (FDA) on January 27 posted an addition to the Class I recall by LivaNova (TandemLife) of its LifeSPARC System Controller. The addition to the recall provides information about a software update now available to address the previous software malfunction and recall. The System…

Read More

By: Judy Mathias
January 30, 2023
Share

Study: Unsafe medical devices gain FDA approval through loophole

Editor's Note A study done by investigators from Yale, Harvard, and the University of California-San Francisco, published on January 10 in JAMA, found that “many medical devices subject to recall had received Food and Drug Administration (FDA) approval based, in part, on the products’ similarities to earlier devices,” Healthcare Purchasing…

Read More

By: Tarsilla Moura
January 27, 2023
Share

FDA: Class I recall of Datascope/Getinge Cardiosave Hybrid, Rescue IABPs

Editor's Note The Food and Drug Administration (FDA) on January 25 identified the recall by Datascope/Gettinge of its Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pumps (IABPs) as Class I, the most serious. The recall was initiated because of the risk that blood may enter the pump through a damaged balloon…

Read More

By: Judy Mathias
January 26, 2023
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat